Cannovum AG

  • WKN: A2LQU2
  • ISIN: DE000A2LQU21
  • Land: Deutschland

Nachricht vom 06.09.2021 | 08:33

Cannovum AG starts European cannabis expansion with founding of Cannovum Iberia LDA

DGAP-News: Cannovum AG / Key word(s): Joint Venture
06.09.2021 / 08:33
The issuer is solely responsible for the content of this announcement.

Cannovum AG (stock exchanges Düsseldorf, Munich, Hamburg, Berlin, gettex: ISIN DE000A2LQU21) has started its European cannabis expansion with its subsidiary, Cannovum Health eG. The first step for this was founding Cannovum Iberia LDA, a joint venture between Cannovum and Portuguese entrepreneurs from the cannabis industry. Cannovum Iberia will initially distribute cannabis pharmaceuticals to pharmacies in Portugal.

The Portuguese pharmaceutical cannabis market is in its early stages. It was not until March 2021 that the first cannabis pharmaceutical, a flower variety, was approved for the Portuguese market. Pharmaceutical cannabis cultivation has been legal in Portugal since 2019, but only as an export product. Now, for the first time, Portuguese patients have access to cannabis-based medicines. The prescription guidelines are similar to German specifications. The German standards for medical cannabis regulations are recognized EU-wide, offering the opportunity to expand into Portugal as well as other European countries. Cannovum Iberia LDA is headquartered in Venda do Pinheiro.

"We have reached the first milestone and successfully completed the founding process of Cannovum Iberia LDA. It's important for us to work with connoisseurs of the local market and to improve the care of Portuguese patients together, because every patient deserves the best therapy," says Pia Marten, CEO of Cannovum AG.

Contact:

Linda Rasch, IR & PR, Cannovum AG
Phone +49 30 3982 163 62, linda.rasch@cannovum.com


Cannovum AG is the first German listed medical cannabis company. The shares are traded on the Düsseldorf, Munich, Berlin, Hamburg and gettex stock exchanges. Through its subsidiary Cannovum Health eG, Cannovum is a fully licensed pharmaceutical wholesaler, importer and manufacturer of high-quality medical cannabis products based in Berlin. The company focuses on the import of high-quality cannabinoid products, medical-scientific education and all-encompassing distribution for simplified and facilitated access to cannabis-based therapies.

For more information, visit www.cannovum.com



06.09.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de



show this

GBC im Fokus

net digital, der digitale und mobile Payment-Spezialist

Die net digital AG agiert mit ihren digitalen und mobilen Paymentlösungen und den hierzu ergänzenden Diensten (z. B. Abo-Management und zahlungsbezogene KI-Lösungen) im multimilliarden-schweren Paymentmarkt. Basierend auf der vielversprechenden Wachstumsstrategie und der guten Marktpositionierung, sollte es dem net digital-Konzern gelingen, ab dem Jahr 2022 ein nachhaltiges dynamisches Wachstum zu erreichen. Parallel hierzu rechnen wir aufgrund des sehr skalierbaren Geschäftsmodells (Plattform-Ansatz) mit einer überproportionalen Ergebnisverbesserung. Bei dem von uns ermittelten Kursziel von 20,60 € vergeben wir das Rating KAUFEN.

News im Fokus

Vonovia SE: Jürgen Fenk und Matthias Hünlein sollen in den Auf-sichtsrat der Vonovia SE einziehen

25. Januar 2022, 10:58

Aktueller Webcast

home24 SE

Trading Update FY 2021

25. Januar 2022

Aktuelle Research-Studie

Original-Research: Ikonisys SA (von Sphene Capital GmbH): Buy Ikonisys SA

25. Januar 2022